Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. recently ...

Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510 (k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation, and ...

Zimmer Biomet and Monogram undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this ...